{
  "retracted": false,
  "timestamp": 1585180800000,
  "updates": [
    {
      "timestamp": 1592484028338,
      "identifier": {
        "doi": "10.1007/s00262-020-02537-4"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00262-019-02456-z"
  },
  "journal": "Cancer Immunology, Immunotherapy",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients"
}
